文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症监护药师执行质量集束化措施对患者结局和费用的影响

Impact of Quality Bundle Enforcement by a Critical Care Pharmacist on Patient Outcome and Costs.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论在法国两家ICU中,重症监护药师提供镇静药物、机械通气模式、抗菌药物降阶梯及导管移除建议,与住院时间、机械通气时间和费用降低相关,对死亡率无影响。

该研究为法国两家ICU(16张和10张床)开展的前后对照研究,比较药师观察期(2013年1月1日至2015年6月30日)与干预期,干预期由重症监护药师就镇静药物及剂量、机械通气模式及相关设置、抗菌药物降阶梯、中心静脉和导尿管移除向临床医生提供建议。按入院时简化急性生理评分II匹配后,两组各1164例可评估。干预期与患者住院时间、ICU住院时间、机械通气时间和每次住院费用降低相关,每月总费用节省10840欧元,主要因镇静药和抗菌药物消耗减少,未发现对死亡率的影响。

要点

  • 按SAPS II匹配后,干预期患者住院时间平均减少3.7天(95%CI 5.2-2.3天,p<0.001)。
  • 干预期ICU住院时间平均减少1.4天(95%CI 2.3-0.5天,p<0.005),机械通气时间平均减少1.2天(95%CI 2.1-0.3天,p<0.01)。
  • 干预期每次住院费用平均减少2560欧元(95%CI 3728-1392欧元,p<0.001),每月总费用节省10840欧元(95%CI 10727-10952欧元)。
  • 费用节省主要来自镇静药和抗菌药物消耗减少。
  • 研究未发现干预对死亡率有影响。

适用人群与场景

  • 法国两家ICU(16张和10张床)收治的ICU患者,按入院时简化急性生理评分II匹配后两组各1164例可评估。

处置流程与药物剂量

  • 干预期由重症监护药师就镇静药物及剂量向临床医生提供建议。
  • 干预期由重症监护药师就机械通气模式及相关设置向临床医生提供建议。
  • 干预期由重症监护药师就抗菌药物降阶梯向临床医生提供建议。
  • 干预期由重症监护药师就中心静脉导管和导尿管移除向临床医生提供建议。

研究设计与关键结果

  • 研究设计为法国两家ICU的前后对照研究,观察期(2013年1月1日至2015年6月30日)与干预期比较,观察期收治1519例、干预期收治1268例,按SAPS II匹配后两组各1164例可评估。
  • 干预期患者住院时间平均减少3.7天(95%CI 5.2-2.3天,p<0.001)。
  • 干预期ICU住院时间平均减少1.4天(95%CI 2.3-0.5天,p<0.005)。
  • 干预期机械通气时间平均减少1.2天(95%CI 2.1-0.3天,p<0.01)。
  • 干预期每次住院费用平均减少2560欧元(95%CI 3728-1392欧元,p<0.001)。
  • 每月总费用节省10840欧元(95%CI 10727-10952欧元),主要因镇静药和抗菌药物消耗减少。
  • 未发现干预对死亡率有影响。

证据类型、等级与局限

  • 证据类型:前后对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,重症监护药师主导的干预与ICU住院时间、住院时间和ICU药物费用降低相关。
  • 研究未发现干预对死亡率有影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Surgical and medical ICU patients are at high risk of mortality and provide a significant cost to the healthcare system. The aim of this study is to describe the effect of pharmacist-led interventions on drug therapy and clinical strategies on ICU patient outcome and hospital costs.

DESIGN: Before and after study in two French ICUs (16 and 10 beds).

PATIENTS: ICU patients.

INTERVENTION: From January 1, 2013, to June 30, 2015, a pharmacist observation period was compared with an intervention period in which a critical care pharmacist provided recommendations to clinicians regarding sedative drugs and doses, choice of mechanical ventilation mode and related settings, antimicrobial de-escalation, and central venous and urinary catheters removal. Differences in ICU and hospital length of stay, duration of mechanical ventilation, mortality rate, and hospital costs per patient were quantified between groups with patients matched for severity of illness (Simplified Acute Physiology Score II) at admission.

MEASUREMENTS AND MAIN RESULTS: From the 1,519 and 1,268 admitted patients during the observation and intervention periods, respectively, 1,164 patients were evaluable in both groups after matching for Simplified Acute Physiology Score II score. The intervention period was associated with mean (95% CI) reductions in patient hospital length of stay (3.7 d [5.2-2.3 d]; p < 0.001), ICU length of stay (1.4 d [2.3-0.5 d]; p < 0.005), duration of mechanical ventilation (1.2 d [2.1-0.3 d]; p < 0.01), and hospital costs per stay (2,560 euros [3,728-1,392 euros]; p < 0.001). The overall cost savings were 10,840 euros (10,727-10,952 euros) per month, mostly due to reduced consumption of sedatives and antimicrobials. No impact on mortality rate was identified.

CONCLUSIONS: Critical care pharmacist-led interventions were associated with decreases in ICU and hospital length of stays and ICU drug costs.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Leguelinel-Blache G, Nguyen TL, Louart B, et al. Impact of Quality Bundle Enforcement by a Critical Care Pharmacist on Patient Outcome and Costs. Crit Care Med. 2018. PMID: 29189346. doi:10.1097/CCM.0000000000002827

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。